Baxter

baxter.com · Deerfield, United States of America

Baxter International Inc. is a global healthcare company that develops, manufactures, and markets medical products including intravenous solutions, infusion systems, renal care and dialysis products, pharmaceuticals, and surgical care devices for hospitals, clinics, and home-care patients. It serves healthcare providers, governments, and patients worldwide through direct sales and distribution partnerships. The company generates revenue by selling its medical devices, consumables, and related therapies, as well as associated services and support programs.

Revenue
$1B+
Employees
5,001+
Founded
1931
Headquarters
Deerfield, United States of America

Baxter customers on Arbolus

Total customers 41 39 current · 2 former
Reviews growth 14 new reviews since May 2026

Customers who reviewed Baxter

Seniority of Baxter customers

Most people who reviewed Baxter hold C-Suite roles (52%), followed by Director (32%) and Manager (15%).

  • C-Suite 52%
  • Director 32%
  • Manager 15%

Customers sample

Other Generalist Director NPS 10 Will renew
Other Partner C-Suite NPS 1
Other Generalist Manager NPS 9

Employer names and spend open in the full report, along with the other 38 customers.

What 41 Arbolus experts think of Baxter

Overall sentiment: Positive

NPS scores are skewed highly positive, with about 60% reporting scores of 8 or above and strong renewal intent among influencers and high spenders. Most experts report being in implementation for over a year, indicating high stickiness. Key feedback themes include superior hemostatic efficacy, operational convenience, and robust bundled offerings, offset by some concerns about preparation timing and storage requirements.

Everything 41 customers told us about Baxter.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

26 Net Promoter Score, from 41 scored reviews
  • Promoters 18
  • Passives 16
  • Detractors 7

Praised

  • Market-Leading Clinical Performance
  • Clinical Outcome Impact
  • Bundled Offerings Across Hospital Needs
  • Expand Cost-Effective Bundles

Criticised

  • Competitor Innovation Risk
  • Storage and Supply Chain Complexity
  • Cost-Pressure Switching Risk
  • High Unit Costs

What Baxter customers say

Market-Leading Clinical Performance

“I view Baxter as a leader for intraoperative hemostasis and tissue sealing, especially in complex surgical cases where rapid bleeding control is critical.”

Other Generalist · Health Care · 10,000+ employees · EMEA

Clinical Outcome Impact

“By using Baxter’s FLOSEAL in complex joint surgeries, we achieve rapid bleeding control and significantly lower our blood transfusion rates post-op.”

Other Generalist · Health Care · 10,000+ employees · EMEA

Bundled Offerings Across Hospital Needs

“Combining high-value bio-pharmaceuticals with essential IV and irrigation fluids lets us secure negotiated pricing across multiple departments.”

Other Generalist · Health Care · 10,000+ employees · EMEA

Renewal intent

Plan to renew 63%
  • Will renew 10
  • Undecided 5
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 50% 8 answers
  • Director 75% 8 answers
  • 8.7/10 Average score from customers who will renew
  • 7.2/10 Average score from undecided customers
  • 0/10 Average score from customers not renewing

Top alternatives

Most weighed by Baxter customers

Report

Nov 2026 41 + 0

For people who use Baxter

Do you use Baxter at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 41 customers of Baxter have already contributed

Takes a few minutes. Your identity stays anonymous.